361 related articles for article (PubMed ID: 24986490)
21. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
22. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
[TBL] [Abstract][Full Text] [Related]
23. A rapidly progressive and fatal case of atypical acute generalized exanthematous pustulosis.
Krishna S; Ortega-Loayza A; Malakouti N; Brinster N
J Am Acad Dermatol; 2014 Sep; 71(3):e89-90. PubMed ID: 25128141
[No Abstract] [Full Text] [Related]
24. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
[TBL] [Abstract][Full Text] [Related]
25. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
26. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
27. Two cases of acute generalized exanthematous pustulosis related to oral terbinafine and an analysis of the clinical reaction pattern.
Eyler JT; Squires S; Fraga GR; Liu D; Kestenbaum T
Dermatol Online J; 2012 Nov; 18(11):5. PubMed ID: 23217946
[TBL] [Abstract][Full Text] [Related]
28. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
Schwartz RA; McDonough PH; Lee BW
J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
30. Severe acute generalized exanthematous pustulosis with blistering, mimicking toxic epidermal necrolysis.
Natkunarajah J; Ostlere L
Clin Exp Dermatol; 2012 Mar; 37(2):188-9. PubMed ID: 21790730
[No Abstract] [Full Text] [Related]
31. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
32. Severe cutaneous adverse reactions to drugs.
Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
[TBL] [Abstract][Full Text] [Related]
33. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
[TBL] [Abstract][Full Text] [Related]
34. Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Scheinfeld N; Wesson K; Perry P; Weinberg J
Acta Derm Venereol; 2003; 83(1):76-7. PubMed ID: 12636039
[No Abstract] [Full Text] [Related]
35. Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J; Schwartz RA
J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
[TBL] [Abstract][Full Text] [Related]
36. Valdecoxib-associated acute generalized exanthematous pustulosis.
Byerly FL; Nelson KC; Granko RP; Morrell DS; Cairns BA
Burns; 2005 May; 31(3):383-7. PubMed ID: 15774300
[TBL] [Abstract][Full Text] [Related]
37. Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime.
Chaabane A; Aouam K; Gassab L; Njim L; Boughattas NA
Fundam Clin Pharmacol; 2010 Aug; 24(4):429-32. PubMed ID: 19925632
[TBL] [Abstract][Full Text] [Related]
38. Acute generalized exanthematous pustulosis induced by piroxicam: a case report.
Cherif Y; Jallouli M; Mseddi M; Turki H; Bahloul Z
Indian J Pharmacol; 2014; 46(2):232-3. PubMed ID: 24741202
[TBL] [Abstract][Full Text] [Related]
39. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Goh TK; Pang SM; Thirumoorthy T; Goh SG
Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
[TBL] [Abstract][Full Text] [Related]
40. Skin signs of severe systemic medication reactions.
Treat JR
Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):193-7. PubMed ID: 22884025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
